[Editorial] Access to medicines—the status quo is no longer an option

September 24, 2016

The Lancet 388, 10051 (2016)

Author: The Lancet

Last week, the much anticipated report of the UN Secretary-General’s High-Level Panel on Access To Medicines, Promoting innovation & access to health technologies, was published. The independent panel sought recommendations to solve the disjunction between trade and the patent system with fulfilment of the right to health. This misalignment continues to be a barrier to affordable access to essential medicines.